1 active not recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Active not recruiting 1 |
Follow Congenital Hyperinsulinism: new trials by email Literature Review of Congenital Hyperinsulinism trials Research Report on Congenital Hyperinsulinism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RZ358 Treatment for Congenital Hyperinsulinism RZ358 (5 mg/kg) + SOC (Standard-of-Care) or Placebo + SOC, RZ358 (10 mg/kg) or Placebo + SOC, RZ358 (5-10 mg/kg) + SOC - Congenital Hyperinsulinism | Phase 3 | Active not recruiting | Rezolute | 56 | 2024-01-11 | 2026-01-08 |
Digestive System Diseases (1) · Glucose Metabolism Disorders (1) · Hyperinsulinism (1) · Hypoglycemia (1) · Metabolic Diseases (1) · Pancreatic Diseases (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Infant, Newborn, Diseases (1) · Nutritional and Metabolic Diseases (1)
Standard of Care (1)
Rezolute (1)
Bulgaria (1) · Denmark (1) · France (1) · Georgia (1) · Germany (1) · Greece (1) · Oman (1) · Qatar (1) · Spain (1) · Turkey (Türkiye) (1) · United Kingdom (1) · United States (1) · Vietnam (1)
Gopal Saha, MD (1)